$0.8800
At close: Jun 17, 11:20 AM EDT
Comments
Loading...
Moberg Pharma Analyst Ratings and Price Targets | OTC:MBGPF | Benzinga
Moberg Pharma Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Moberg Pharma Corp from these most-recent analyst ratings.
Analyst Ratings for Moberg Pharma
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for Moberg Pharma (MBGPF) stock?
There is no price target for Moberg Pharma
What is the most recent analyst rating for Moberg Pharma (MBGPF)?
There is no analyst for Moberg Pharma
When was the last upgrade for Moberg Pharma (MBGPF)?
There is no last upgrade for Moberg Pharma
When was the last downgrade for Moberg Pharma (MBGPF)?
There is no last downgrade for Moberg Pharma.
When is the next analyst rating going to be posted or updated for Moberg Pharma (MBGPF)?
There is no next analyst rating for Moberg Pharma.
Is the Analyst Rating Moberg Pharma (MBGPF) correct?
There is no next analyst rating for Moberg Pharma.
Browse analyst ratings and price targets on all stocks.
